Itraconazol Tecnigen

Itraconazole, the active ingredient in Itraconazol Tecnigen, is an azole antifungal presented as an oral dosage form for oral use. It treats a range of systemic and superficial fungal infections in adults and children when prescribed by a healthcare professional.

GNH USA supplies Itraconazol Tecnigen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Itraconazole is used to treat fungal infections across several disease categories.

Candidiasis: treatment of systemic and mucosal infections caused by Candida species. Aspergillosis: management of invasive disease caused by Aspergillus spp. Dermatophytosis: therapy of skin infections such as tinea corporis and tinea pedis. Blastomycosis: treatment of infections caused by Blastomyces dermatitidis. Histoplasmosis: management of disseminated disease due to Histoplasma capsulatum. Sporotrichosis: therapy of infections caused by Sporothrix schenckii.

Itraconazole may cause a variety of adverse reactions, ranging from mild to severe.

Common Side Effects: - Nausea and vomiting - Abdominal pain or dyspepsia - Headache - Rash or pruritus - Altered taste perception - Diarrhea

Serious or Rare Side Effects: - Hepatotoxicity, including hepatitis and liver failure - Severe skin reactions such as Stevens‑Johnson syndrome or toxic epidermal necrolysis - Congestive heart failure or new‑onset edema - Cardiac arrhythmias - Visual disturbances or optic neuritis

Before initiating therapy, clinicians should assess patient-specific risk factors and monitor for potential complications. - Liver monitoring: Perform baseline and periodic liver function tests because hepatotoxicity can occur. - Cardiac assessment: Avoid use in patients with existing heart failure or significant edema. - Drug interaction review: Evaluate concomitant medications that may affect itraconazole metabolism. - Pregnancy and lactation: Use only if the potential benefit outweighs the risk; discuss with a healthcare provider. - Storage below 25°C: keep in the original container, protect from moisture and light.

Itraconazole has a high potential for pharmacokinetic interactions due to CYP3A4 inhibition.

Major Interactions (Avoid): - Rifampin, carbamazepine, phenytoin, or St. John's wort, which markedly reduce itraconazole levels. - Ketoconazole or other strong azole antifungals, increasing risk of toxicity. - Certain protease inhibitors that can cause dangerous elevations in itraconazole concentrations.

Moderate Interactions (Monitor Closely): - Warfarin, as itraconazole may enhance anticoagulant effect. - Oral contraceptives, which may have reduced efficacy when taken with itraconazole.